How long can you take cabozantinib for liver cancer?

Cabozantinib is a second-line treatment for liver cancer, and its duration of use mainly depends on the patient's treatment response. For those patients who respond well to cabozantinib, treatment may continue for a longer period of time. However, treatment may need to be interrupted or adjusted if the disease progresses or the patient develops intolerable side effects.

According to clinical data, cabozantinib has shown certain efficacy in the treatment of liver cancer. For example, in one study, patients who received cabozantinib had a significantly longer progression-free survival (PFS) compared with those who received placebo. This suggests that, for a subset of patients with liver cancer, cabozantinib can lead to longer-term disease control.

Specific to each patient, the duration of cabozantinib use will be affected by a variety of factors, including but not limited to the patient's liver function status, the size and location of the tumor, the presence of metastasis, and the patient's overall health status.

Although cabozantinib has certain efficacy, it may also cause some side effects, such as diarrhea, fatigue, high blood pressure, etc. The severity of these side effects varies from person to person and may affect how long a patient takes the medication. If side effects are too severe, patients may need to reduce the dose or suspend treatment under the guidance of their doctor.

During the treatment process, the doctor will regularly evaluate the patient's condition and drug response, and adjust the treatment plan as needed. Therefore, the treatment duration of cabozantinib for liver cancer patients is not fixed, but needs to be dynamically adjusted according to the patient's specific situation.